• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习方法分析急性护理环境中哮喘加重的患者特征。

A machine learning approach to characterize patients with asthma exacerbation attending an acute care setting.

机构信息

Department of Respiratory Medicine, Federico II University, Naples, Italy.

Istituti Clinici Scientifici Maugeri IRCCS, Cardiac Rehabilitation Unit of Telese Terme Institute, Telese Terme, Italy.

出版信息

Eur J Intern Med. 2022 Oct;104:66-72. doi: 10.1016/j.ejim.2022.07.019. Epub 2022 Jul 31.

DOI:10.1016/j.ejim.2022.07.019
PMID:35922367
Abstract

BACKGROUND

One of the main problems in poorly controlled asthma is the access to the Emergency Department (ED). Using a machine learning (ML) approach, the aim of our study was to identify the main predictors of severe asthma exacerbations requiring hospital admission.

METHODS

Consecutive patients with asthma exacerbation were screened for inclusion within 48 hours of ED discharge. A k-means clustering algorithm was implemented to evaluate a potential distinction of different phenotypes. K-Nearest Neighbor (KNN) as instance-based algorithm and Random Forest (RF) as tree-based algorithm were implemented in order to classify patients, based on the presence of at least one additional access to the ED in the previous 12 months.

RESULTS

To train our model, we included 260 patients (31.5% males, mean age 47.6 years). Unsupervised ML identified two groups, based on eosinophil count. A total of 86 patients with eosinophiles ≥370 cells/µL were significantly older, had a longer disease duration, more restrictions to daily activities, and lower rate of treatment compared to 174 patients with eosinophiles <370 cells/μL. In addition, they reported lower values of predicted FEV (64.8±12.3% vs. 83.9±17.3%) and FEV/FVC (71.3±9.3 vs. 78.5±6.8), with a higher amount of exacerbations/year. In supervised ML, KNN achieved the best performance in identifying frequent exacerbators (AUROC: 96.7%), confirming the importance of spirometry parameters and eosinophil count, along with the number of prior exacerbations and other clinical and demographic variables.

CONCLUSIONS

This study confirms the key prognostic value of eosinophiles in asthma, suggesting the usefulness of ML in defining biological pathways that can help plan personalized pharmacological and rehabilitation strategies.

摘要

背景

控制不佳的哮喘的主要问题之一是需要进入急诊部(ED)。本研究采用机器学习(ML)方法,旨在确定需要住院治疗的严重哮喘恶化的主要预测因子。

方法

在 ED 出院后 48 小时内,对哮喘加重的连续患者进行筛选以纳入研究。实施 k-均值聚类算法以评估不同表型的潜在区别。实施 K-最近邻(KNN)作为实例基算法和随机森林(RF)作为树基算法,以根据患者在过去 12 个月中至少有一次额外进入 ED 的情况对其进行分类。

结果

为了训练我们的模型,我们纳入了 260 名患者(31.5%为男性,平均年龄 47.6 岁)。无监督 ML 根据嗜酸性粒细胞计数确定了两组。嗜酸性粒细胞≥370 个/µL 的患者显著更年长,疾病持续时间更长,日常生活受限更多,治疗率更低,而嗜酸性粒细胞<370 个/μL 的患者则相反。此外,他们报告了较低的预计 FEV(64.8±12.3% vs. 83.9±17.3%)和 FEV/FVC(71.3±9.3 vs. 78.5±6.8)值,每年哮喘加重的次数更多。在有监督 ML 中,KNN 在识别频繁加重者方面表现最佳(AUROC:96.7%),这证实了肺量计参数和嗜酸性粒细胞计数以及先前加重次数和其他临床及人口统计学变量的重要性。

结论

本研究证实了嗜酸性粒细胞在哮喘中的关键预后价值,表明 ML 在定义可帮助制定个性化药物治疗和康复策略的生物学途径方面的有用性。

相似文献

1
A machine learning approach to characterize patients with asthma exacerbation attending an acute care setting.机器学习方法分析急性护理环境中哮喘加重的患者特征。
Eur J Intern Med. 2022 Oct;104:66-72. doi: 10.1016/j.ejim.2022.07.019. Epub 2022 Jul 31.
2
Spirometry use in children hospitalized with asthma.肺活量测定法在哮喘住院儿童中的应用。
Pediatr Pulmonol. 2014 May;49(5):451-7. doi: 10.1002/ppul.22854. Epub 2013 Sep 2.
3
Novel Machine Learning Can Predict Acute Asthma Exacerbation.新型机器学习可预测哮喘急性加重
Chest. 2021 May;159(5):1747-1757. doi: 10.1016/j.chest.2020.12.051. Epub 2021 Jan 10.
4
Machine learning approaches for predicting disposition of asthma and COPD exacerbations in the ED.机器学习方法在急诊中预测哮喘和 COPD 加重的处置。
Am J Emerg Med. 2018 Sep;36(9):1650-1654. doi: 10.1016/j.ajem.2018.06.062. Epub 2018 Jun 28.
5
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.美泊利珠单抗治疗嗜酸粒细胞性哮喘的疗效分层:基于基线嗜酸粒细胞阈值的 DREAM 和 MENSA 研究的二次分析。
Lancet Respir Med. 2016 Jul;4(7):549-556. doi: 10.1016/S2213-2600(16)30031-5. Epub 2016 May 10.
6
Novel Machine Learning Identifies 5 Asthma Phenotypes Using Cluster Analysis of Real-World Data.基于真实世界数据的聚类分析,新型机器学习可识别 5 种哮喘表型。
J Allergy Clin Immunol Pract. 2024 Aug;12(8):2084-2091.e4. doi: 10.1016/j.jaip.2024.04.035. Epub 2024 Apr 27.
7
Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain.真实世界回顾性观察研究,旨在确定西班牙重度哮喘的患病率和经济负担。
J Med Econ. 2020 May;23(5):492-500. doi: 10.1080/13696998.2020.1719118. Epub 2020 Feb 6.
8
Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.气流受限疾病患者在基层医疗环境中的病情加重情况及医疗资源利用:PUMA研究
Int J Chron Obstruct Pulmon Dis. 2016 Dec 7;11:3059-3067. doi: 10.2147/COPD.S120776. eCollection 2016.
9
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis.基线呼出气一氧化氮(FeNO)作为 LIBERTY ASTHMA QUEST 研究中接受安慰剂治疗的未控制的中重度哮喘患者随后发生严重哮喘加重的预后生物标志物:一项事后分析。
Lancet Respir Med. 2021 Oct;9(10):1165-1173. doi: 10.1016/S2213-2600(21)00124-7. Epub 2021 Jun 25.
10
Obese, non-eosinophilic asthma: frequent exacerbators in a real-world setting.肥胖型非嗜酸性粒细胞性哮喘:真实世界环境中的常见加重因素。
J Asthma. 2022 Nov;59(11):2267-2275. doi: 10.1080/02770903.2021.1996598. Epub 2021 Oct 28.

引用本文的文献

1
Risk prediction of cholangitis after stent implantation based on machine learning.基于机器学习的支架植入术后胆管炎风险预测。
Sci Rep. 2024 Jun 14;14(1):13715. doi: 10.1038/s41598-024-64734-w.
2
Artificial Intelligence in Optimizing the Functioning of Emergency Departments; a Systematic Review of Current Solutions.人工智能在优化急诊科运作中的应用;当前解决方案的系统综述
Arch Acad Emerg Med. 2024 Jan 27;12(1):e22. doi: 10.22037/aaem.v12i1.2110. eCollection 2024.
3
Artificial Intelligence: Exploring the Future of Innovation in Allergy Immunology.
人工智能:探索过敏免疫学生物学创新的未来。
Curr Allergy Asthma Rep. 2023 Jun;23(6):351-362. doi: 10.1007/s11882-023-01084-z. Epub 2023 May 9.